Maolan Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Surgery top 2%
- Cholangiocarcinoma and Gallbladder Cancer Studies
Papers in
- Surgery 54
- Cholangiocarcinoma and Gallbladder Cancer Studies 53
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Yingbin Liu (60 shared papers)Xiangsong Wu (45 shared papers)Jiasheng Mu (31 shared papers)Hao Weng (31 shared papers)Yang Cao (21 shared papers)Runfa Bao (32 shared papers)Yijun Shu (26 shared papers)Zhujun Tan (19 shared papers)
- Journals
- Cancer Letters (6 papers)Tumor Biology (5 papers)BMC Cancer (3 papers)Signal Transduction and Targeted Therapy (3 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Maolan Li
96 papers receiving 3.3k citations
Maolan Li's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 556
- Surgery 1.1k
- Oncology 472
- Pharmacology 201
- Molecular Biology 772
Countries citing papers authored by Maolan Li
This map shows the geographic impact of Maolan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maolan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maolan Li more than expected).
Fields of papers citing papers by Maolan Li
This network shows the impact of papers produced by Maolan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maolan Li. The network helps show where Maolan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Maolan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway Hit paper breakdown → | 2014 | 359 |
| 2 | 2014 | 210 | |
| 3 | 2018 | 151 | |
| 4 | Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer Hit paper breakdown → | 2021 | 150 |
| 5 | 2014 | 99 | |
| 6 | 2016 | 98 | |
| 7 | 2014 | 85 | |
| 8 | 2013 | 83 | |
| 9 | 2017 | 80 | |
| 10 | 2017 | 78 | |
| 11 | 2015 | 69 | |
| 12 | 2013 | 68 | |
| 13 | 2014 | 63 | |
| 14 | 2013 | 62 | |
| 15 | 2014 | 59 | |
| 16 | 2017 | 58 | |
| 17 | 2015 | 55 | |
| 18 | 2015 | 55 | |
| 19 | 2011 | 52 | |
| 20 | 2014 | 52 |
About Maolan Li
Maolan Li is a scholar working on Surgery, Cancer Research, Oncology, Pharmacology and Hepatology, having authored 99 papers that have together received 3.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (53 papers), Pancreatic and Hepatic Oncology Research (8 papers), Gastric Cancer Management and Outcomes (6 papers), Cancer-related molecular mechanisms research (6 papers), Flavonoids in Medical Research (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Natural Compounds in Disease Treatment (3 papers) and Natural product bioactivities and synthesis (3 papers). The work is most often cited by research in Cancer Research (556 citations), Surgery (1.1k citations), Oncology (472 citations), Pharmacology (201 citations) and Molecular Biology (772 citations). Maolan Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yingbin Liu, Xiangsong Wu, Jiasheng Mu, Hao Weng, Yang Cao, Runfa Bao, Yijun Shu, Zhujun Tan, Qichen Ding and Wenguang Wu. Their work appears in journals such as Cancer Letters, Tumor Biology, BMC Cancer, Signal Transduction and Targeted Therapy and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.